SOUTH Korean health authorities said on Friday they would request imports of Gilead Sciences Inc’s anti-viral drug remdesivir to treat COVID-19, as new outbreaks of the disease flare as social distancing restrictions are eased.
Sign up Newsletter
Make sure to subscribe to our newsletter and be the first to know the news.